Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Blood

• Publication date

  2000-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V96.1.358.013K16_358_361PMID 10891474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry.

  2000cited by this paper
• Telomere stability is frequently impaired in high-risk groups of patients with myelodysplastic syndromes.

  1999cited by this paper
• Telomere dynamics, end-to-end fusions and telomerase activation during the human fibroblast immortalization process

  1999cited by this paper
• Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia

  1999cited by this paper
• Progressive telomere shortening in aplastic anemia.

  1998cited by this paper
• Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.

  1998cited by this paper
• Accelerated telomere shortening in young recipients of allogeneic bone-marrow transplants.

  1998cited by this paper
• Progressive Telomere Shortening in Aplastic Anemia

  1998cited by this paper
• Telomere length in myelodysplastic syndromes

  1997cited by this paper
• Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression

  1997cited by this paper
• The relationship between telomere length and therapy‐associated cytogenetic responses in patients with chronic myeloid leukemia

  1997cited by this paper
• Telomerase activity in human breast tumors.

  1996cited by this paper
• Telomeric DNA in normal and leukemic blood cells.

  1995cited by this paper
• Telomerase activity in normal leukocytes and in hematologic malignancies.

  1995cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia.

  1995cited by this paper
• UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

  1995cited by this paper
• Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes.

  1994cited by this paper
• Specific association of human telomerase activity with immortal cells and cancer.

  1994cited by this paper
• Chronic myelogenous leukemia: a concise update.

  1993cited by this paper
• Structure and function of telomeres

  1991cited by this paper
• Telomere reduction in human colorectal carcinoma and with ageing

  1990cited by this paper
• Structure and function of telomeres.

  1989cited by this paper
• Blood.

  1989cited by this paper

• The Telomere Length Signature in Leukemias—From Molecular Mechanisms Underlying Telomere Shortening to Immunotherapeutic Options Against Telomerase

  2025influential citation
• Role of telomere length in human carcinogenesis (Review)

  2023cites this paper
• High-Throughput Human Telomere Length Analysis at the Single-Chromosome Level by FISH Coupled with Nano-Flow Cytometry.

  2021cites this paper
• Telomere dynamics in adult hematological malignancies.

  2019cites this paper
• Telomere length measurement as a clinical biomarker of aging and disease

  2018influential citation
• Telomeres and Telomerase in Hematopoietic Dysfunction: Prognostic Implications and Pharmacological Interventions

  2017cites this paper
• Telomere length and human telomerase reverse transcriptase (hTERT) level in patients with acute myeloid leukemia: Impact on clinical outcome

  2015cites this paper
• The characterisation of telomere dynamics in Myelodysplastic syndromes

  2014cites this paper
• Zachowanie długości telomerów Maintaining telomere length

  2013cites this paper
• leukemia with special reference to VH gene mutation status Telomere length as a prognostic parameter in chronic lymphocytic

  2013cites this paper
• [Maintaining telomere length].

  2013cites this paper
• Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy.

  2013cites this paper
• Telomere dynamics in chronic myeloid leukaemia

  2013cites this paper
• Telomere loss in Philadelphia-negative hematopoiesis after successful treatment of chronic myeloid leukemia: evidence for premature aging of the myeloid compartment.

  2012cites this paper
• Gene Expression Analysis of Telomerase Related Genes in Myeloid Malignancy

  2012cites this paper
• Telomere dysfunction and its role in haematological cancer

  2012influential citation
• A new dic(7;12)(p12.21;p12.2) and i(12)(q10) during the lymphoid blast crisis of patient with Ph+ chronic myeloid leukemia

  2012cites this paper
• Telomere length as prognostic parameter in chronic lymphocytic leukemia

  2011cites this paper
• Telomere biology in hematopoiesis and stem cell transplantation.

  2011cites this paper
• Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.

  2011cites this paper
• Pathophysiology of Chronic Myeloid Leukemia

  2011cites this paper
• The role of telomeres and telomerase complex in haematological neoplasia: the length of telomeres as a marker of carcinogenesis and prognosis of disease.

  2010cites this paper
• Targeting telomerase in hematologic malignancy.

  2010cites this paper
• Allogeneic stem cell transplantation in treatment of chronic myeloid leukaemia – current approach in tyrosine kinase inhibitors era

  2010cites this paper
• High-density single nucleotide polymorphism array analysis and ASXL1 gene mutation screening in chronic myeloid leukemia during disease progression

  2010cites this paper
• Genetic instability in inherited and sporadic leukemias

  2010cites this paper
• Telomerase regulation in hematological cancers: a matter of stemness?

  2009cites this paper
• Telomere length is severely and similarly reduced in JAK2V617F-positive and -negative myeloproliferative neoplasms

  2009cites this paper
• Diagnostic Value II: Hematopoietic Malignancies

  2009cites this paper
• The promise of telomere length, telomerase activity and its regulation in the translocation-dependent cancer ESFT; clinical challenges and utility.

  2009cites this paper
• Telomere length as a biological marker in malignancy.

  2009cites this paper
• Telomere length - inheritance pattern and role as a biomarker

  2008cites this paper
• TELOMERE AND STEM CELL BIOLOGY IN CHRONIC MYELOID LEUKEMIA

  2008cites this paper
• Concise Review: Telomere Biology in Normal and Leukemic Hematopoietic Stem Cells

  2007cites this paper
• Molecular cytogenetic markers related to prognosis in hematological malignancies

  2006cites this paper
• Telomere and telomerase in hematologicalmalignancies.

  2006cites this paper
• Diagnostics, prognostic and therapeutic exploitation of telomeres and telomerase in leukemias.

  2006cites this paper
• Telomeres and telomerase in stem cells during aging and disease.

  2006cites this paper
• Molecular profiling of CD34+ cells identifies low expression of CD7, along with high expression of proteinase 3 or elastase, as predictors of longer survival in patients with CML.

  2006cites this paper
• hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia

  2006cites this paper
• Nonmyeloablative Conditioning Does Not Prevent Telomere Shortening after Allogeneic Stem Cell Transplantation

  2005cites this paper
• The importance of the telomere and telomerase system in hematological malignancies

  2005cites this paper
• Telomere length and hTERT expression in patients with acute myeloid leukemia correlates with chromosomal abnormalities.

  2005cites this paper
• Molecular profiling of CD34+ cells identifies low expression of CD7 with high expression of proteinase 3 or elastase as predictors of longer survival in CML patients (*)

  2005cites this paper
• Telomere Shortening Correlates with Prognostic Score at Diagnosis and Proceeds Rapidly during Progression of Chronic Myeloid Leukemia

  2004cites this paper
• Telomere length as a prognostic parameter in chronic lymphocytic leukemia with special reference to VH gene mutation status.

  2004cites this paper
• Mechanisms of regression.

  2004cites this paper
• Clonal evolution in chronic myelogenous leukemia.

  2004cites this paper
• Clinical results with imatinib in chronic myeloid leukaemia.

  2004cites this paper
• Telomere shortening impairs organ regeneration by inhibiting cell cycle re‐entry of a subpopulation of cells

  2003cites this paper
• Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells.

  2003cites this paper
• Role of constitutively activated protein tyrosine kinases in malignant myeloproliferative disorders: an update

  2003cites this paper
• The role of interleukin-3 and stem cell factor in classical Hodgkin disease.

  2003cites this paper
• Normalization of Previously Shortened Telomere Length under Treatment with Imatinib Argues against a Preexisting Telomere Length Deficit in Normal Hematopoietic Stem Cells from Patients with Chronic Myeloid Leukemia

  2003cites this paper
• Telomere dynamics in childhood leukemia and solid tumors: a follow-up study

  2003cites this paper
• Stem cell transplantation for chronic myeloid leukemia: impact of imatinib mesylate

  2003cites this paper
• Telomeres in Myelodysplastic Syndrome and Its Related Disorders: Does Telomere Length Reflect Stem Cell Turnover in Clonal Hematopoietic Disorders?

  2003cites this paper
• Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia

  2003cites this paper
• Telomere analysis of normal and neoplastic hematopoietic cells : studies focusing on fluorescence in situ hybridization and flow cytometry

  2003cites this paper
• Role of c-Jun NH-terminal Kinase in Bcr/Abl Induced Cell Transformation: a dissertation

  2003cites this paper
• Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia.

  2003cites this paper
• Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia.

  2003cites this paper
• chromosome 9 in chronic myeloid leukemia Double jeopardy from a single translocation : deletions of the derivative

  2003cites this paper
• Chronic myelogenous leukemia: A review and update of therapeutic strategies

  2003cites this paper
• Quantitative analysis of mixed chimerism following allogeneic bone marrow transplantation using telomere flow-FISH

  2003cites this paper
• Telomeres and telomerase in hematologic neoplasia

  2002cites this paper
• Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis

  2002cites this paper
• Telomere Length in Haemopoietic Stem Cells can be Determined from that of Mononuclear Blood Cells or Whole Blood

  2002cites this paper
• Telomere length in peripheral blood granulocytes reflects response to treatment with imatinib in patients with chronic myeloid leukemia

  2002cites this paper
• Chronic myelogenous leukemia.

  2002cites this paper
• Hepatocyte telomere shortening and senescence are general markers of human liver cirrhosis.

  2002cites this paper
• Molecular cytogenetic aspects of hematological malignancies: clinical implications.

  2002cites this paper
• Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia

  2002cites this paper
• The impact of clonal evolution on response to imatinib mesylate (STI571) in accelerated phase CML.

  2002cites this paper
• Recent publications in hematological oncology.

  2001cites this paper
• Telomerase in human tumors: molecular diagnosis andclinical significance

  2001cites this paper
• Shortened telomere length is demonstrated in T‐cell subsets together with a pronounced increased telomerase activity in CD4 positive T cells from blood of patients with mycosis fungoides and parapsoriasis

  2001cites this paper
• Molecular evolution of chronic myeloid leukaemia.

  2001cites this paper
• Chronic myelogenous leukemia.

  2001cites this paper
• Anti-Aging Medicine LiteratureWatch

  2000cites this paper